Left Main PCI Technique Could Change DAPT Duration

Up to 20% of patients undergoing left main PCI require a 2-stent technique, and this number should most likely grow after the DKCRUSH-V outcomes. However, this study contradicts the DKCRUSH-V and brings us back to “the simpler the better”, since patients undergoing 1 stent left main PCI presented less revascularization and less target vessel failure than patients undergoing 2 stent PCI. Even more, it suggests extending DAPT when using a 2-stent technique.

La ATC es una alternativa válida en el TCIThe aim of this study was to assess the impact of DAPT duration according to the chosen technique to treat left main bifurcations.

 

Researchers analyzed 5 multicenter registries looking into a combination of target vessel failure and thrombotic events, in addition to differences in the individual components. They carried out a subgroup analyzis according to DAPT duration.


Read also: DKCRUSH-V: What Is Simple Is Not Always Best for the Left Main Coronary Artery.


Of the 13172 registry patients undergoing PCI with new generation stents, 700 received left main bifurcation PCI (567 with 1 stent and 133 with 2 stents).

 

Target vessel failure and revascularization rates were higher in the 2-stent group (most lesions were more anatomically complex).

 

Thrombotic event risk was comparable between both strategies, though the subgroup analyzis showed the 2-stent group had a significantly higher risk when receiving DAPT for 1 year, while the risk was similar when DAPT went on for longer.  


Read also: EXCEL-QOL Substudy: Similar Quality of Life both with CABG and Left Main PCI.


This study shows that complex PCI might help redefine DAPT duration.

 

Original title: Dual Antiplatelet Therapy Duration Determines Outcome After 2- But Not 1-Stent Strategy in Left Main Bifurcation Percutaneous Coronary Intervention.

Reference: Tae-Min Rhee et al. J Am Coll Cardiol Intv 2018;11:2453–63.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...